Clinical Observation on Bushen Yiqi Tong luo Huazhuo Prescrip tion for Diabetic Neph ropathy at Early Stage
Author:
Affiliation:
Fund Project:
摘要
|
图/表
|
访问统计
|
参考文献
|
相似文献
|
引证文献
|
资源附件
|
文章评论
摘要:
目的:观察补肾益气通络化浊方治疗糖尿病肾病早期的临床疗效。方法:将糖尿病肾病早期患者120例,随机分为对照组和治疗组各60例。对照组予常规西医疗法治疗,治疗组在对照组基础上予补肾益气通络化浊方治疗,2组均治疗1年。比较2组临床疗效、治疗前后中医证候积分、空腹血糖(FBG)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、24h尿蛋白定量、尿微量白蛋白、尿白蛋白排泄率(UAER)、血清肌酐(SCr)、血尿素氮(BUN)、白细胞介素6(IL-6)、IL-1β、超敏C-反应蛋白(hs-CRP) 及终点事件发生率。结果:治疗后,总有效率对照组为65.0%,治疗组为90.0%,2组比较,差异有统计学意义( P <0.05)。治疗后,2组FBG、TC、TG、LDL-C、24h尿蛋白定量、尿微量白蛋白、BUN、SCr、UAER、IL-6、IL-1β、hs-CRP水平均较治疗前降低( P <0.05),治疗组上述指标较对照组降低更明显( P <0.05);2组HDL-C水平均较治疗前升高( P <0.05),治疗组HDL-C水平较对照组升高更明显( P <0.05)。治疗后,终点事件发生率对照组为63.3%,治疗组为18.3%,2组比较,差异有统计学意义( P <0.05)结论:补肾益气通络化浊方治疗糖尿病肾病早期,能降低血糖和血脂水平,减少蛋白尿,改善肾功能,延缓疾病进展。
Abstract:
Objective:To observe the clinical effect of BushenYiqiTongluoHuazhuo prescription for diabetic nephropathy at early stage.Methods:Divided 120 cases of patients with diabetic nephropathy at early stage into the control group and thetreatment group randomly,60 cases in each group.The controlgroup received routine westernmedicine for treatment,while the treatment group was additionally given BushenYiqiTongluoHuazhuo prescription based on the treatment of the control group.The two groups received treatment for one year.Compared the clinicaleffect,scores of Chinese medicine syndromes,fasting blood glucose(FBG),triglyceride(TG),total cholesterol(TC),low density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),24h urine protein excretion,urinary microalbumin,urinary albumin excretion rate(UAER),serum creatinine(SCr),blood urea nitrogen(BUN),interleukins-6(IL-6),IL-1β ,high-sensitivity C-reactive protein(hs-CRP)before and after treatment and the incidence of endpoint events in the two groups.Results: After treatment, the total effective rate was 65.0%in the control group and 90.0%in the treatment group,the difference being significant( P <0.05).After treatment,levels of FBG,TC,TG,LDL-C,24h urine protein excretion,urinary microalbumin,BUN,SCr,UAER,IL-6,IL-1β and hs-CRP in the two groups were decreased when compared with those before treatment( P <0.05),and the decrease of the above indexes in the treatment group were more obvious than those in the control group( P <0.05).Levels of HDL-C in the two groups were increased when compared with those before treatment( P <0.05),and the increase in the treatment group was more obvious than that in the controlgroup( P <0.05).After treatment,the incidence of endpoint events was 63.3%in the controlgroup and 18.3%in the treatment group,the difference being significant( P <0.05).Conclusion:The therapy of BushenYiqiTongluoHuazhuo prescription for diabetic nephropathy at early stage can reduce the levels of blood glucose and blood lipid,decrease proteinuria,improve the kidney function and delay the development of disease.